Homeopathic formulation for Flu and Flu like symptoms.

Not Applicable

Completed

• Conditions: Health Condition 1: J101- Influenza due to other identifiedinfluenza virus with other respiratory manifestations

• Registration Number: CTRI/2019/09/021351
• Lead Sponsor: Bhargava Phytolab Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-10-04
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

The Inclusion criteria are as follows (â??Yesâ?? to all the following will allow the subjects to be included into study)

1 Age: Adult-Above 18 years to below 60 years, both male and female

2 Willing to sign written inform consent

3 Patients recently diagnosed with Flu, the following signs and symptoms

Diagnosis of Mild to Moderate Headache, Body ache and other symptoms of cough cold.

Sore throat.

Sneezing/ Nasal irritation.

Headache.

Cough.

Runny nose.

Malaise.

With or without low grade fever ( <102 F)

Exclusion Criteria

The exclusion criteria are as follows (â??Yesâ?? to any one of the following will allow PI to exclude the subject from enrolling into the study

1 Upper Respiratory Tract Infections (URI or URTI) including rhinitis, sinusitis, pharyngitis, tonsillitis, laryngitis, tracheitis and otitis media.

2 Lower Respiratory Tract Infections (LRI or LRTI) including pneumonia and acute bronchitis.

3 Chronic obstructive airway disease (COAD) including chronic bronchitis and emphysema

4 Bronchial Asthma

5 H/o Pulmonary Tuberculosis

6 Tumours of larynx, bronchi, and lungs

7 Drug-induced Cough (e.g., ACE Inhibitors)

8 Diabetes Mellitus, Hypertension

9 Known cases of severe hepatic, renal or cardiac ailments

10 H/o addiction (smoking, alcohol, drugs)

11 K/h/o hypersensitivity to herbal extracts or dietary supplements

12 Pregnant women, lactating women and women of child-bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy test.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptomatic relief from clinical symptoms of Flu and Flu like symptomsTimepoint: 7 Days

Secondary Outcome Measures

Name	Time	Method
To assess the safety profile of Anacosinum pellets in Flu and overall compliance to the drug treatment.Timepoint: 7 Days